148 related articles for article (PubMed ID: 15696403)
1. Antibody engineering--IBC's 15th Annual International Conference. 30 November-3 December 2004, San Diego, CA, USA.
Haurum JS
IDrugs; 2005 Feb; 8(2):91-3. PubMed ID: 15696403
[No Abstract] [Full Text] [Related]
2. IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.
Arnett SO; Teillaud JL; Wurch T; Reichert JM; Dunlop C; Huber M
MAbs; 2011; 3(2):133-52. PubMed ID: 21304271
[TBL] [Abstract][Full Text] [Related]
3. Antibody Engineering--IBC's 17th annual international conference. Antibody engineering and immunotherapeutics for the 21st century.
Bradbury A
IDrugs; 2007 Mar; 10(3):169-72. PubMed ID: 17351868
[No Abstract] [Full Text] [Related]
4. IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.
Nilvebrant J; Dunlop DC; Sircar A; Wurch T; Falkowska E; Reichert JM; Helguera G; Piccione EC; Brack S; Berger S
MAbs; 2012; 4(2):153-81. PubMed ID: 22453091
[TBL] [Abstract][Full Text] [Related]
5. IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA.
Klöhn PC; Wuellner U; Zizlsperger N; Zhou Y; Tavares D; Berger S; Zettlitz KA; Proetzel G; Yong M; Begent RH; Reichert JM
MAbs; 2013; 5(2):178-201. PubMed ID: 23575266
[TBL] [Abstract][Full Text] [Related]
6. IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.
Marquardt J; Begent RH; Chester K; Huston JS; Bradbury A; Scott JK; Thorpe PE; Veldman T; Reichert JM; Weiner LM
MAbs; 2012; 4(6):648-52. PubMed ID: 23007482
[TBL] [Abstract][Full Text] [Related]
7. Protein Engineering for Biotherapeutics--IBC's second annual conference. Developing and improving next generation biotherapeutics.
Smider V
IDrugs; 2007 Mar; 10(3):176-7. PubMed ID: 17351870
[No Abstract] [Full Text] [Related]
8. Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.
Larrick JW; Parren P; Huston JS; Plückthun A; Bradbury A; Tomlinson IM; Chester KA; Burton DR; Adams GP; Weiner LM; Scott JK; Alfenito MR; Veldman T; Reichert JM
MAbs; 2014; 6(5):1115-23. PubMed ID: 25517297
[TBL] [Abstract][Full Text] [Related]
9. Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.
Larrick JW; Alfenito MR; Scott JK; Parren PW; Burton DR; Bradbury AR; Lemere CA; Messer A; Huston JS; Carter PJ; Veldman T; Chester KA; Schuurman J; Adams GP; Reichert JM
MAbs; 2016; 8(8):1425-1434. PubMed ID: 27557809
[TBL] [Abstract][Full Text] [Related]
10. Genetics in profile. IBC's Conference on Genetic Profiling and Diagnostics, San Diego, CA, USA, 29-30 October, 1997.
Strausberg RL
Trends Genet; 1998 Feb; 14(2):50-1. PubMed ID: 9520596
[No Abstract] [Full Text] [Related]
11. Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.
Pauthner M; Yeung J; Ullman C; Bakker J; Wurch T; Reichert JM; Lund-Johansen F; Bradbury AR; Carter PJ; Melis JP
MAbs; 2016; 8(3):617-52. PubMed ID: 26909869
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic angiogenesis and wound healing--IBC's International Conference. 15-16 November 2004, Cambridge, MA, USA.
Rubanyi GM
IDrugs; 2005 Feb; 8(2):94-6. PubMed ID: 15696404
[No Abstract] [Full Text] [Related]
13. Therapeutic antibodies and antibody fusion proteins.
Rohrbach P; Broders O; Toleikis L; Dübel S
Biotechnol Genet Eng Rev; 2003; 20():137-63. PubMed ID: 14997850
[No Abstract] [Full Text] [Related]
14. IBC's conference on antibody engineering; new technology, application and commercialisation.
Wilton J; Braddock P; Smith S; Smith S
Expert Opin Investig Drugs; 1998 May; 7(5):835-8. PubMed ID: 15991973
[TBL] [Abstract][Full Text] [Related]
15. IBC's conference on pulmonary hypertension: new understanding for therapeutic development.
Bialecki RA
Expert Opin Investig Drugs; 1998 Apr; 7(4):653-8. PubMed ID: 15992001
[TBL] [Abstract][Full Text] [Related]
16. Antibody engineering--IBC's Tenth International Conference. 6-9 December 1999, La Jolla, CA, USA.
Carter P
IDrugs; 2000 Mar; 3(3):259-61. PubMed ID: 16103927
[TBL] [Abstract][Full Text] [Related]
17. Engineering antibody therapeutics.
Chiu ML; Gilliland GL
Curr Opin Struct Biol; 2016 Jun; 38():163-73. PubMed ID: 27525816
[TBL] [Abstract][Full Text] [Related]
18. Engineering Antibodies for the Treatment of Infectious Diseases.
Fan G; Li J
Adv Exp Med Biol; 2017; 1053():207-220. PubMed ID: 29549641
[TBL] [Abstract][Full Text] [Related]
19. Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.
Almagro JC; Gilliland GL; Breden F; Scott JK; Sok D; Pauthner M; Reichert JM; Helguera G; Andrabi R; Mabry R; Bléry M; Voss JE; Laurén J; Abuqayyas L; Barghorn S; Ben-Jacob E; Crowe JE; Huston JS; Johnston SA; Krauland E; Lund-Johansen F; Marasco WA; Parren PW; Xu KY
MAbs; 2014; 6(3):577-618. PubMed ID: 24589717
[TBL] [Abstract][Full Text] [Related]
20. Engineering at the limits of antibody space.
Huston JS
Protein Eng Des Sel; 2013 Oct; 26(10):559-60. PubMed ID: 24077692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
